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SEX HORMONE THERAPY IN EXPERIMENTAL
PERIPHERAL GANGRENE*
R. M. THOMAS
The administration of ergot or ergot derivatives has been shown
to result in a continuous spasm of the muscular coat of peripheral
arteries, leading to cyanotic induration, ulceration, and, in many
instances, to gangrene of the tissues.1' 25,7 In 1935, McGrath
reported4 that female albino rats could be protected from the more
severe manifestations of ergotamine intoxication by the daily injec-
tion of ovarian follicular hormone (Theelin). He found that male
rats similarly treated with Theelin were not protected, although the
onset of ulceration and gangrene was delayed. In view of the
greater incdence of peripheral vascular disease in men as compared
with women, these experimental findings attracted considerable
interest. Further reports on the use of ovarian hormone therapy
in experimental ergotamine intoxication were published in 1938 by
Loewe and Lenke8 and by Suzmann, Freed, andPrag.' Employing
the methods used by McGrath, Loewe and Lenke were unable to
produce gangrene in the tails of all their rats by a single injection.
They found, however, that divided doses given over a three-day
period did result in the development of gangrene in 100 per cent
of their animals. They then tested the effects of Theelin and of
Progynon-B (Schering), as well as the effects of castration of male
rats, on the course of ergotamine intoxication. With daily doses of
from 2 to 10 rat units of Theelin per day, as recommended by
McGrath, no changes were noted; the amount was raised to 30 rat
units and finally to 500 rat units per day of Progynon-B without
effect.
On the other hand Suzmann, Freed, and Prag, using similar
methods, reported that repeated daily doses of 500 I. U. of cestro-
form afforded female rats complete protection from gangrene of
the tail, while male rats were only slightly affected. It must be
noted that while no definite quantitative relationship- can be deter-
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mined between "rat units" and International Units, a rat unit is
considered from 3 to 12 times as effective as an International Unit.
Thus, the dosage used by Loewe and Lenke, and found to be ineffec-
tive, exceeded that used by Suzmann and his colleagues. These
discrepances led to repetition of the experiments both with ergo-
tamine alone and with sex hormones.
Materials and methods
White rats weighing 150 gm. were used. They were placed on a
standard ration of fox chow, oats, and greens, and observed for several days
prior to the beginning of the experiment. They were all in good health and
active. The ergot preparation used was ergotamine tartrate (Gynergen,
Sandoz) and was dissolved in distilled water made slightly acid with tartaric
acid. Theelin (aqueous solution) was used as a source of ovarian hormone.
Two groups of ten male and two groups of ten female rats were injected
subcutaneously with 5 mg. of ergotamine tartrate. One group of female rats
and one group of male rats were subsequently injected with 20 I.U. of
Theelin per day for a period of 28 days. The other groups served as controls.
All rats were examined daily, and drawings were made of any unusual
appearances of the tails.
Results
Four rats died within 24 hours following the injection of
ergotamine. The others were acutely ill and showed loss of appe-
tite and diminished activity for the first 24 hours, but returned to
normal in appearance and behavior by 36 to 48 hours. During the
following 20 days 7 ofthe rats receiving Theelin exhibited a marked
cyanosis of the tail and 3 of these developed gangrene. In the
control group 7 showed cyanosis and of these, 4 developed gangrene.
In both groups the females showed as much change as did the
males, in some instances a greater change. There was no uniform-
ity in the rate at which these changes occurred; some rats developed
gangrene within 5 days after the injection, and one rat had sloughed
several centimeters of tail within 36 hours. Others exhibited only
cyanosis after 15 or 20 days. Among these there were no differ-
ences referable to sex. No further changes were noted after 20 days.
From the results of this experiment it was evident that the
amount of ergotamine required to produce vascular changes was
sufficient to endanger the life of the animal. In an attempt to
increase the incidence of vascular change a second experiment was
carried out in which ergotamine was injected repeatedly; an initial
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dose of 7 mg. was followed in 19 days by a second dose of 3.5 mg.,
10 days later by a dose of 5 mg., and 29 days later, or 54 days after
the first injection, by a final dose of 5 mg. Thirty rats were used,
and were divided into the following groups: 10 females which were
treated with 20 I. U. of Theelin per day; 10 males treated with
0.5 mg. of testosterone propionate dissolved in peanut-oil; 5 female
and 5 male rats, untreated, served as controls.
These injections of sex hormones were commenced five days
prior to the first injection of ergotamine and were continued for 93
days. The results of sex hormone therapy were equivocal. As in
the first experiment, the control rats and the treated rats developed
vascular changes in the same proportion. There was no indication
that the repeated injection of ergotamine was more effective than a
single dose. Approximately one fourth of the animals died within
24 hours after an injection of ergotamine, but there was no orderli-
ness in this phenomenon; some rats succumbed to the first injection,
some to the third or fourth. A few rats developed gangrene after
the first injection, while a small number showed no change until
the third or fourth injection. Those rats which had developed
gangrene early were seemingly unaffected by later injections of
ergotamine. All in all there was very little evidence-that the
vascular changes induced by ergotamine are in any way constant.
A group of S rats injected with ergotamine daily for 3 days accord-
ing to the method of Loewe and Lenke expired within a few hours
after the last injection.
All of the animals were autopsied and histological sections were
prepared from the parenchymatous organs, the aorta, and the tail.
No findings referable to the experimental procedures were observed
in any of the internal organs or in the blood vessels of the trunk.
The tails were removed and sections prepared from the distal and
proximal portions; usually four separate blocks were chosen, from
the base to the tip of the tail or to the most distal healthy tissue.
Changes of various types were observed in the central arteries and
in the arterioles, almost all of which involved a proliferation of the
intimal tissue. Many arterioles in the distal portion of the tails
were found to be ocduded by overgrowth of the intimal layer; the
central arteries showed similar changes ranging from eccentric pro-
liferations to complete occlusion of the lumen. It was of interest
that in those rats which failed to show clinical alterations in the tail
or showed only slight congestion or cyanosis, no histological changes418 *YALE JOURNAL OF BIOLOGY AND MEDICINE
were found; while in those rats which showed gangrene it was not
uncommon to find extensive changes in the central artery even at the
root ofthe tail many centimeters proximal to the line of demarcation
between healthy and involved tissue. In none of the vessels which
showed intimal change was there any evidence of thrombus forma-
tion, except in the portion which was obviously gangrenous. In
addition to the changes noted in the vessels there was evidence that
the prolonged cyanosis and induration were accompanied by a diffuse
proliferation of the connective tissue elements of the subcutaneous
tissue and around the blood vessels.
Conclusions
The administration of either male or female sex hormones to
albino rats had no effect on the incidence of gangrene of the tail
induced by -ergotamine tartrate. The severity of the changes
induced by ergotamine was likewise not altered by hormone therapy.
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